Biodignity

History

2023: Launch of production of Russia's first industrial production of mRNA vaccine components

In early December 2023, the Biosan group announced the launch of the first mass production of components in Russia to create mRNA vaccines against viral, bacterial infections and oncological diseases. Of these components, as the deputy head of the company Vladimir Richter explained to journalists, any mRNA can be collected.

Let's imagine that the vaccine or mRNA drug must be assembled from them. There are many cubes, they are different, each has its own color. There are chemical cubes, there are enzymatic cubes, there are biotechnological cubes. It is quickly unrealistic to get these cubes, you need a lot of equipment and competencies in different areas - chemical synthesis, fermenters for enzyme expansion, and chromatographic equipment, - he specified (quote from TASS).

The Biosan group announced the launch of the first mass production of components for the creation of mRNA vaccines

The company also produces reagents for molecular biology, biochemistry and diagnostics that were previously purchased abroad, Richter said. He clarified that it was possible to organize the production of some of these components, which are not actually purchased now. There is a production of a whole range of PCR kits, it was significantly possible to squeeze out imported competitors. According to him, Russia has achieved an importonic dependence on these reagents.

Biosan produces enzymes for molecular biology, isolation DNA and RNA kits, reagents for creating mRNA vaccines, PCR kits used in scientific research, to medicine and. In the agriculture laboratory of the Biolink company, test systems are manufactured with the help of which oncology can be detected even in the early stages - Novosibirsk researchers were the first in Russia to learn to detect the smallest traces of a tumor in the blood. The company develops and implements molecular genetic diagnostics methods in oncology: reagent kits for tumor analysis in melanoma, lung cancer, breast cancer, colorectal cancer.^[1]

Notes